ArticleInternal and emergency medicine2015
Early failure of noninvasive ventilation in chronic obstructive pulmonary disease with acute hypercapnic respiratory failure.
Article in Internal and emergency medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04427826 (Efficacy of Morphine in Reducing the Rate of Early Non-Invasive Ventilation), which is not on this map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Efficacy of Morphine in Reducing the Rate of Early Non-Invasive Ventilation (NIV) Failure in Acute Exacerbation of Chronic Obstructive Pulmonary Disease (COPD), Phase I/IIa
Who cites it
12 citing papers in PubMed.
- Trial
- Integrating validated scores with clinical parameters to predict NIV weaning outcomes: a prospective study in the respiratory ICU.Scientific reports · 2026Observational
- Prediction of noninvasive ventilation failure: a narrative review.Annals of intensive care · 2026Review
- Respiratory Infection Triggering Severe Acute Exacerbations of Chronic Obstructive Pulmonary Disease.International journal of chronic obstructive pulmonary disease · 2024Article
- Timing of Treatment Outcomes and Risk Factors for Failure of BPAP in Patients Hospitalized for COPD Exacerbation.Respiratory care · 2022Article
- Early prediction of noninvasive ventilation failure in COPD patients: derivation, internal validation, and external validation of a simple risk score.Annals of intensive care · 2019Article
- Update: non-invasive ventilation in chronic obstructive pulmonary disease.Journal of thoracic disease · 2018Review
- Evidence-based Utilization of Noninvasive Ventilation and Patient Outcomes.Annals of the American Thoracic Society · 2017Article
- Impact and prevention of severe exacerbations of COPD: a review of the evidence.International journal of chronic obstructive pulmonary disease · 2017Review
- Hospital Noninvasive Ventilation Case Volume and Outcomes of Acute Exacerbations of Chronic Obstructive Pulmonary Disease.Annals of the American Thoracic Society · 2016Article
- Early failure of noninvasive ventilation in COPD: All cornerstones under surveillance?Internal and emergency medicine · 2016Article
- Effectiveness assessment of a guideline based protocol for ventilatory support management of COPD exacerbations in an emergency department.Brazilian journal of physical therapyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Noninvasive ventilation (NIV) in the management of chronic obstructive pulmonary disease (COPD) patients with acute hypercapnic respiratory failure is considered a first-line therapy. However, patients who fail NIV and then require invasive mechanical ventilation have been found to have higher mortality than patients initially treated with invasive mechanical ventilation. We tried to find parameters associated with early NIV failure (need for intubation or death <24 h of starting NIV) in patients presenting to the ED with acute exacerbation of COPD. A retrospective analysis was conducted of the medical records of 218 patients with acute exacerbation of COPD visiting Asan Medical Center and managed with NIV during their stay in the ED from January 2007 to December 2013. NIV was successful in 200 (91.7%) and 18 (8.3%) had early NIV failure. Of the variables obtained before NIV treatment, heart rate (≥120/min: OR 2.5, 95% CI 1.2-7.0) and pH (7.25-7.29: OR 2.1, 95% CI 1.0-8.8; <7.25: OR 11.7, 95% CI 3.5-38.6) were significant factors associated with early NIV failure. Of the variables obtained after 1 h of NIV treatment, heart rate (≥120/min: OR 7.5, 95% CI 2.3-24.3) and pH (7.25-7.29: OR 4.7, 95% CI 1.5-15.1; <7.25: OR 20.9, 95% CI 5.4-61.2) were still significant. The presence of tachycardia and severe acidosis before NIV treatment and persistence of tachycardia and severe acidosis after 1 h of NIV treatment were associated with early NIV failure.
Indexed as
Identifiers
26341216What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.